Report Highlights
- Explains the concept and role of biotechnology based products in pharmaceutical industry.
- Analysis of the benchmarking categories: Therapeutic proteins, gene therapies, blood components and derivatives, vaccines, allergenics, devices.
- Critical analysis of marketed products and R&D products in each category.
- Market trends.
- Description of the key stages in the drug development pathway that a new drug candidate has to go through.
- In depth evaluation of the main technologies in biotechnology research: bioinformatics, genomics, microarrays, proteomics, and pharmacogenomics.
- Overview of biotechnology based pharmaceutical industry in the U.S., Europe, Canada and Asia/Pacific focused on key therapy areas, promising approved products, technologies and regional product approval agencies/guidelines.
- Analysis of key medical conditions that drive biotechnology based research and drug development, comparison with available standard hormonal/chemical treatments for the same.
- Company focused evaluation of major players in the industry - forecasts and business strategies.
INTRODUCTION
SCOPE AND CONTENT
- Explanation of the concept and role of biotechnology based products in pharmaceutical industry.
- Analysis of the benchmarking categories: Therapeutic proteins, gene therapies, blood components and derivatives, vaccines, allergenics, devices.
- Critical analysis of marketed products and R&D products in each category.
- Market trends.
- Description of the key stages in the drug development pathway that a new drug candidate has to go through.
- In depth evaluation of the main technologies in biotechnology research: bioinformatics, genomics, microarrays, proteomics, and pharmacogenomics.
- Overview of biotechnology based pharmaceutical industry in the U.S., Europe, Canada and Asia/Pacific focused on key therapy areas, promising approved products, technologies and regional product approval agencies/guidelines.
- Analysis of key medical conditions that drive biotechnology based research and drug development, comparison with available standard hormonal/chemical treatments for the same.
- Company focused evaluation of major players in the industry - forecasts and business strategies.
- The products included in the estimations and forecasts are the major drivers of the market.
- Sales data from the previous years was reviewed assuming that the past trends will continue in the future.
- Where sales data for a full year was unavailable an estimate of the full year sales was made.
Related Reports
Recent Reports
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials
The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.
Global Cleanroom Technology Market
The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.
Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets
The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.
Microelectromechanical Systems (MEMS) in Global Medical Markets
The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Non-Fungible Tokens (NFT): Global Market
The global NFTs market should reach $37.6 billion by 2022 and $125.6 billion by 2027, with a compound annual growth rate (CAGR) of 27.3% during the forecast period of 2022-2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More